bradykinin analog peptides (University of Michigan)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namebradykinin analog peptides (University of Michigan)
Drug Alias NameThrombostatinpeptide thrombin inhibitors (Thromgen/University of Michigan)thrombostatins (Thromgen/University of Michigan)MAP4-TH146FM-19 +[6] 
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionFactor IIa inhibitorsProtease-activated receptor-1 antagonistsProtease-activated receptor-4 antagonists +[4] 
TargetsProtease-activated receptor-1Protease-activated receptor-4Prothrombin
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Michigan
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThromgen IncUniversity Of Michigan
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A